AlTi Global’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-112,615
Closed -$2.67M 466
2025
Q4
$2.67M Sell
112,615
-12
-0% -$292 0.06% 138
2025
Q3
$2.8M Buy
112,627
+4
+0% +$86 0.07% 136
2025
Q2
$2.59M Buy
112,623
+8
+0% +$185 0.07% 140
2025
Q1
$2.53M Sell
112,615
-50,000
-31% -$1.16M 0.07% 126
2024
Q4
$3.18M Hold
162,615
0.08% 116
2024
Q3
$2.96M Hold
162,615
0.07% 124
2024
Q2
$2.83M Hold
162,615
0.08% 120
2024
Q1
$3.19M Hold
162,615
0.09% 113
2023
Q4
$3.75M Buy
+162,615
New +$3.64M 0.11% 91

Other funds holding PRVA

AlTi Global's PRVA Position: Q1 2026 in Review

AlTi Global sold out of Privia Health (PRVA) in Q1 2026, closing a stake of 112,615 shares — an estimated $2.67M sold.

AlTi Global first reported a position in PRVA in Q4 2023 and held it in 9 quarters. The position peaked at $3.75M in Q4 2023. 293 funds tracked by Wall St. Rank hold PRVA as of Q1 2026.

  • AlTi Global reported no remaining Privia Health position as of Q1 2026 after selling out during the quarter.
  • AlTi Global sold 112,615 Privia Health shares in Q1 2026, an estimated $2.67M.
  • AlTi Global first reported a position in Privia Health in Q4 2023 and held it in 9 quarters.
  • AlTi Global's Privia Health position peaked at $3.75M in Q4 2023.
  • 293 funds tracked by Wall St. Rank held Privia Health as of Q1 2026.

Based on AlTi Global's 13F filing for Q1 2026, filed 7 May 2026.